Brief description of study

To assess the efficacy of Lanreotide Autogel 120 mg for the relief of vomiting due to
inoperable malignant intestinal obstruction in patients without nasogastric tube (NGT) and to
assess the efficacy of lanreotide Autogel 120 mg on removal of nasogastric tube without the
recurrence of vomiting in patients with an inoperable malignant intestinal obstruction with a
nasogastric tube.